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Abstract

Design and Development of Platforms for the Application of Loop-mediated Isothermal Nucleic
Acid Amplification, LAMP, in the Diagnosis of Polymicrobial Diseases
Tochukwu Dubem Anyaduba, Travis Schlappi (PI)

For the past two decades, several isothermal nucleic acid amplification technologies have emerged.
These are mostly in response to the need for robust molecular diagnostic tools amenable to pointof-care and limited-resource settings. Of these, loop-mediated isothermal amplification, LAMP,
stands out as a highly specific and rapid alternative to the polymerase chain reaction, PCR. One of
LAMP's significant characteristics involves using four essential and two loop (rate increasing)
primers to recognize six to eight (6 – 8) distinctive regions in a target DNA sequence. While the
assortment of primers makes LAMP highly specific, it also poses a challenge to its exploitation in
multiplex molecular diagnostics. Several published methods present means of adopting LAMP in
multiplexing; however, only very few can detect up to four targets within the same sample stream.
Our research's overall goal is to develop platforms capable of exploiting LAMP's high degree of
specificity in identifying 9+ pathogens within the same sample stream using rapid prototyping/
simplistic technologies. This goal is fundamental in diagnosing polymicrobial diseases such as
urinary tract infections, diarrheal diseases, respiratory tract infections, and other diseases whose
attendant symptoms compel uninformed prescriptions. To meet this need, we designed multiple
methods and developed unit processes toward achieving a more promising platform, A Primer
Payload Platform (P3). The P3 is borne out of the ideology that the isolation of LAMP primer sets
and their specific target DNA moieties in micro-reaction vesicles from a single reaction mix could
aid the differential detection of multiple targets without the limitations attendant to current
multiplexing systems. Thus, as a first step toward achieving the P3, we adopted methods for a
multifaceted use of beads (as pathogen identity signatures, primer-delivery machinery, and specific
target DNA carriers). Secondly, we employed simplistic rapid prototyping methodologies to
develop microfluidic cartridges to generate highly monodisperse picoliter-scale droplets. As these
droplets are digital-LAMP and digital PCR-ready, we further applied them to detect and quantify
Escherichia coli and Lactobacillus acidophilus genomic DNA. Finally, we developed a
mechanism for the encapsulation of the beads in picoliter-scale droplets. By unifying the droplet

formation and bead introduction rates at the flow-focusing junction, we recorded more singlebead-carrying droplets than predicted by Poisson statistics. While we do not have a perfect system
for single-particle encapsulation, we achieved higher single bead encapsulation than ever reported
in systems using rapid prototyping for microfluidics or dense bead manipulation.
Our vision is to fully integrate these unit processes into a unified microfluidics-based platform for
polymicrobial diseases molecular diagnostics at the point of care. We believe this platform will
enable timely and precise healthcare interventions within patients' first clinic visits.
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Chapter 1: Introduction and Scope of Thesis
The Big Picture
Medical diagnostics drives about 70% of health care interventions1,2. Without more precise and
targeted interventions, by the year 2050, the world will lose 10 million lives annually due to
antimicrobial resistance3. This forecast puts a toll on healthcare professionals as well as researchers
to develop more effective antimicrobial agents. More importantly, it underscores the lacuna in
infectious disease diagnostic efficiency as a means of improving antimicrobial stewardship. It also
stresses the importance of timely interventions, pathogen escape mitigation, and a focus on limitedresource settings that experience higher disease burden. As a yardstick for measuring the
achievement of these diagnostic milestones, the WHO instituted the ASSURED (affordable,
sensitive, specific, user-friendly, rapid and robust, equipment-free, and deliverable to the enduser)4 criteria, thus emphasizing the importance of inexpensive and simplistic molecular diagnostic
platforms.

Unfortunately, the gold standard in infectious disease diagnostics remains the propagation,
isolation, and identification of the etiologic agent(s), perhaps using microbiological techniques.
Although this technique has been used successfully since Robert Koch and Martinus Beijerinck5,
its application is limited to only etiologic agents cultured in controlled environments (e.g., culture
media). Because of the multiple time-prohibitive steps, successful application of this technique in
medical diagnostics often takes between 2 to 4 days for mono-pathogenic diseases and more for
polymicrobial infectious diseases. Handling also requires advanced training and containment
infrastructure, making it unfit to solve the re-emerging challenges that require timely interventions.
Some of these challenges were solved by the advent of culture-independent diagnostic methods
such as immunoassays (enzyme-linked immunosorbent assay - ELISA, enzyme-multiplied
immunoassay technique - EMIT), matrix-assisted laser desorption/ionization-time of flight
(MALDI-TOF), Biochemical assays (e.g., catalase test, Voges Proskauer), flow cytometry, and
most importantly, nucleic acid (NA) amplification such as quantitative polymerase chain reaction
(qPCR) and isothermal nucleic acid amplification (iNAT) 5–8.
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Owing to the specificity of nucleic acid amplification and testing (NAAT) methods compared to
other culture-independent methods and its wide application, NAAT remains the method of choice
with PCR as its gold standard9,10. Unfortunately, although qPCR is successful in detecting as little
as ~100 fg of target DNA in a sample stream11, its demerits include its complexity, energy
demand,12 instrument cost (between $49 – $80k)13, slow turnaround time compared to isothermal
methods, and its sensitivity to sample matrix. These make qPCR less attractive for use at point-ofcare or limited-resource settings, thus favoring iNAT14.

iNAT technologies became attractive due to their low complexity, rapid turnaround time, lowcost, high amplicon yield15. They also have low energy demand – as amplification is carried out at
a single temperature, thereby eliminating the need for complex thermal cycling instrumentation.16
These attributes also made them amenable for use in point-of-care settings. Unlike qPCR, several
modifications or technologies exist under iNAT. These include NASBA (nucleic acid sequencebased amplification), RPA (recombinase polymerase amplification), LAMP (loop-mediated
isothermal amplification), CPS (cross-priming amplification), HDA (helicase-dependent
amplification), NEAR (nicking enzyme amplification reaction), etc17–21. Of these, LAMP is the
most researched and adapted for use at point-of-care (POC) and resource-poor settings16,22.

Problem Statement
NAAT is a tri-stage process involving sample preparation, NA amplification, and detection.
Despite advances made in the technology, its application in diagnosing polymicrobial infectious
diseases (multiplexing) is often only achieved with a trade-off of specificity or sensitivity. These
challenges are mostly attendant to the two later stages, amplification and detection.
During amplification, primers specific for the proliferation of a region in the target organism's NA
anneal to specific regions. This process is achieved with little or no challenges when only one
etiologic agent is of interest. Its complexity increases with an increase in the number of targets,
and consequently, the number of primers species needed. This complexity is especially true for
LAMP, in which 4 - 6 primers are essential for both increased specificity and speed of amplifying
a specific target13,16,18. The assortment of the primer species in the reaction mix often increases the
risk of non-specific amplification23, competitive amplification – one target is amplified more than
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the others24,25, in most cases unsuccessful amplification due to reduced mobility/ interaction of the
primers with their targets.

The Essence of Multiplexing
Multiplexing in molecular diagnostics has become increasingly important due to the need to screen
for multiple pathogens and increase sensitivity, specificity26, and inclusivity. The ability to screen
for numerous molecular biomarkers also increases the chance for a more precise prescription
within the first clinic visit. Respiratory tract infections, diarrheal diseases, urinary tract infections,
including cancers, are all conditions that could present symptoms triggered by a myriad of
possibilities. How do you attend to these at the point of care without conducting a barrage of tests
and screenings? Multiplexing provides a unique way of screening for multiple (molecular)
biomarkers to offer timely interventions.
There are two methods of choice use in addressing some of these challenges, spatial and spectral
differentiation27,28.

Spatial Differentiation
As illustrated in Fig. 1.1 below, in spatial differentiation, pre-treated samples are distributed into
multiple wells, each containing primers for the amplification of a specific NA target. While this
achieves the much-needed multiplexing, it sacrifices the sensitivity of the assay, as the distribution
further dilutes the concentration of the target nucleic acid in the sample stream. Thus, the assay
could be reported as negative if the limit of detection of the assay is not low enough to detect low
copy numbers of the target nucleic acid.

There is also a possibility that the well will not receive any specific targets, even though it is
present in the primary sample. This false-negative result could complicate patient conditions;
therefore, it is most undesirable. To solve this problem, most devices (e.g., Cepheid GeneXpert,
BioFire FilmArray) and researchers29,30 use a dual amplification (amplify-distribute-amplify
again) process. Through this process, the first amplification step proliferates all NAs present in the
sample stream before distribution into wells, thus compensating for the sensitivity. Although this
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seems to address the problem, it increases the instrument's complexity by including fluidic
modules, valves, more reagents, longer turnaround time, etc.

Fig. 1.1 Illustration of spatial multiplexing and its major demerits

These all add to an increased cost to the consumer, thus making it unideal for use in low and
middle-income (LMIC) or low-resource settings. The 2-stage amplification is also not ideal for
iNAT (especially LAMP), considering the possibility of competitive amplification. The
multiplicity of primers required to amplify all the targets may also lead to non-specific
amplification and the possibility of product inhibition.

Spectral Differentiation
An alternative to the spatial technique is spectral differentiation. Molecular events leading to the
detection of different etiologic agents are monitored using fluorophore-labeled primers or probes
in polymicrobial disease diagnostics.
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Thus, the excitation and emission spectra of each fluorophore are used as a tracer for the
identification of a specific target. Unfortunately, only a maximum of 4 to 6 spectral (excitation and
emission) signaling can be achieved with minimal crosstalk (Fig.1.2).
The spectral overlap is avoided because it leads to the generation of false signals and the loss of
specificity (i.e., false-positive results can be produced). This makes it difficult to achieve

CHROMA.COM

multiplexing without spatial differentiation.

Fig. 1.2 Demonstration of crosstalk among cy5 (649/670), FAM (492:518), Hex (533:559), and
Texas Red (595:620)

The challenges attendant to both techniques described above make it exceptionally difficult to
develop assays and devices targeted at diagnosing polymicrobial infectious diseases at POC and
limited-resource settings using nucleic acid amplification technologies such as LAMP. Thus,
diseases such as lower respiratory and urinary tract infections are still difficult to diagnose without
the use of culture-dependent techniques. Another major challenge, especially with LAMP, is the
propensity for false priming31 or secondary structure formation leading to false positives. This
impacts antibiotic stewardship and is mostly experienced during multiplexing due to the high
number of primers needed for the successful amplification of each target.
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Unfortunately, both methods discussed above are not ideal for higher-order multiplexing with
LAMP, especially because the 2-stage amplification would require a combination of PCR or
RPA32 (stage1) and LAMP (stage 2), thus defeating one of the objectives of POC diagnostics, rapid
turnaround time.
In improving the applicability of LAMP in higher-order multiplexing, challenges bordering on
detection and amplification must therefore be solved. Hence, the objective of this research is to
design and develop novel platforms that would enhance the exploitation of LAMP and other iNAT
in higher-order multiplexing.

Research Approach
To achieve higher-order multiplexing (9+) without the limitations discussed above, an important
factor in controlling was the plurality of the primers within the reaction mix. With this in mind,
we designed some ideas:

1. Diauxic-Like Batch Multiplexing
We proposed controlled delivery of LAMP primers using a principle called diauxic batch
multiplexing (DBM). In principle, DBM will solve two major problems common to multiplex
pathogen detection, primer dimerization and spectral overlap.

Primer Delivery
It has been shown that it is possible to specifically amplify up to three DNA targets per reaction
vessel using LAMP with a low risk of primer dimerization22. Consequently, we proposed the use
of a fed-batch delivery of primers into the reaction vessel, as shown in Figure 1.3 (a-c). This way,
only primers required for targeting three pathogens are available for amplification at any point in
time. For example, screening for about nine DNA targets is broken into three batches with primers
that target only three pathogens available per batch (Fig.1.3).

To control the number of primer sets available for reaction, the successive batches introduce both
their primers and the preceding batch's primer-blocking oligonucleotides. The primer-blocking
oligonucleotides anneal to unused primers from the preceding batch, thus blocking them from
6

interfering with the current batch. With each batch amplification running for about 30 or fewer
minutes, screening for nine pathogens will be concluded in 90 minutes with high sensitivity and
specificity.

Fig. 1.3 (a-c) Illustration of the principle of diauxic-like batch multiplexing (DBM)
Here, capitalized alphabets represent target nucleic acid, the lower-case alphabets represent
primers (forward inner primer, backward inner primer, forward outer primer, backward outer
primer, forward loop primer, and backward loop primer) for each corresponding target. The
colored lines represent the three fluorophores used for the three experimental batches. Batch 1
shows that pathogen A is not present, but pathogens B & C are present; in batch 2, pathogens D
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and F are present while E is not present; in batch 3, none of the pathogens G, H, and I are present.
Note that the starting fluorescence threshold of each successive batch is the maximum fluorescence
of the previous.
Detection
As only three pathogens are targeted per batch, only three fluorophores are used in the entire
process. The maximum fluorescence signals from preceding batch amplification serve as the
threshold for the next batch. This gives the fluorescence signal a unique characteristic curve, as
shown in Figure 1.4. The curve would resemble the growth response curve of E. coli in response
to media containing both glucose and lactose, thus giving it the name "diauxic-like." It is hoped
that the fluorescence signals will also be used for automation for the release of primer-blockers.
Thus, only blockers to the primers whose fluorescence signals did not increase in the preceding
batch will be released to avoid introducing non-functional oligonucleotides, which could introduce
non-specificity. A major assumption to the fluorescence signaling is that each preceding batch
relative fluorescence would not saturate the photodiode's detection limit.

Fig. 1.4 Illustration of the integration of batches 1 – 3 fluorescence signals and their interpretation

Outcome
While this seemed like a good idea, all experiments showed an increased difficulty of continuing
to batch two after batch one amplifications. Among other things, it also revealed the possibility of
quenching amplification using primer-blocking sequences (Fig. 1.5). A major confounding factor
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with DBM experiments was the propensity for carryover contamination due to the re-opening of
LAMP vials to introduce successive batches, hence, its justifiable discontinuation.

Fig. 1.5 The addition of primer blocking oligos into the amplification mix (Blocker + standard),
and the pre-treatment of primers with the blocker - ex situ, yields the same result as NTC. In
comparison, amplification with the standard primers was positive.

2. Temperature-Dependent Cascaded Lamp Multiplexing, TCLM
Much like DBM, TCLM involves a programmed release of locked nucleic acids (LNAs) primers
immobilized onto amplification vesicles. The LNAs are programmed in such a way that their
melting temperature, Tm, corresponds to the batch amplification temperature. For example, the
release of batch 1 primers could be designed to occur at a temperature of 60oC which would also
be the amplification temperature for batch 1. Batch 2 can be programmed to occur at a higher
temperature. The same primer blocking mechanism will be employed to ensure that residual
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primers from a previous batch would not interfere with the next. This presents an advantage over
DBM considering that the ease of automation.

Fig. 1.6 Illustration of 6-plex TCLM

A modified version of the TCLM involves the encapsulation of batch primers in wax (aliphatic
hydrocarbons) which can also be programmed to become Tm-dependent.

3. Primer Payload Platform, P3
As a third alternative, we explored the use of the primer payload platform which involves the
adoption of three major technologies:
•

Bead-based Spectral Sharing

10

•

Digital Droplet Loop-mediated Isothermal Amplification (ddLAMP)

•

Bead Encapsulation

As summarized in Fig.1.7, these three methodologies are combined to become a primer-payload
system for the delivery of target-specific primers and NA targets into defined picoliter-scale
reaction vesicles. Shown in Fig. 1.8 are preliminary designs of the device and microfluidic
cartridge showing different compartments for the different unit processes.
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FIG. 1.7 Illustration of the primer payload platform, P3

12

Fig. 1.8 Original device & cartridge designs
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Bead-Based Spectral Sharing
Stefan Rödiger et al.33 showed the possibility of differentiating bead populations based on the ratio
of the gray values of the infused fluorescent dyes. In combination with the diameter of the beads,
it is possible to derive several population clusters or signatures, Fig 1.7.

Fig. 1.9 Bivariate plot of PopId by bead diameter showing population clusters.

As shown in Fig.1.9, by employing only two fluorophores, rhodamine and coumarine, infused in
polymethylmetacrylate (PMMA) beads of two different diameters, it is possible to differentiate 12
bead clusters. By mapping each cluster as a signature to a particular molecular target, higher order
multiplexing (12) can be achieved without the challenges of spectral crosstalk. This method is
dubbed spectral sharing as only two fluorophores are used for all the targets, albeit at different
ratios.
ddLAMP
In comparison to bulk nucleic acid amplification methods, droplet digital (isothermal) nucleic acid
amplification, dd(i)NAT, allows for single NA detection in a sample stream. This is achieved by
compartmentalizing the bulk solution into smaller reaction vesicles bound by thermostable
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hydrophobic interfaces. Apart from the increased sensitivity which this method offers, it provides
a method for the quantification of target DNA concentration in the bulk sample (equation 1)
without the need for a standard curve.
𝐶𝑜𝑛𝑐 =

𝑁𝑛𝑒𝑔
⁄ )
−ln(
𝑁
𝑉𝑑𝑟𝑜𝑝𝑙𝑒𝑡

equation 1

Where 𝑁𝑛𝑒𝑔 = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑑𝑟𝑜𝑝𝑙𝑒𝑡𝑠, 𝑁 = 𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑟𝑜𝑝𝑙𝑒𝑡𝑠, 𝑉𝑑𝑟𝑜𝑝𝑙𝑒𝑡 =
𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑑𝑟𝑜𝑝𝑙𝑒𝑡

Bead Encapsulation
By encapsulating microparticles in distinct reaction vesicles, researchers have been able to analyze
single cells34, apply LAMP35 in pathogen detection, as well as perform single cell barcoding and
sequencing36. All these rely on the ideology of increased sensitivity and specificity, as well as high
throughput performance.
By employing this technology, we will be creating a system for high throughput screening,
decreased time to positive results, increased statistical relevance of our results, increased
sensitivity & specificity as well as a phenomenal improvement to multiplexing with LAMP.
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Scope of Thesis
The scope of this thesis is to develop the above-mentioned unit systems which will enable the
development of the primer payload platform. By combining these technologies, we would create
a system for conveying LAMP primers and their specific targets into distinct reaction vesicles for
amplification. As such, my thesis is geared at answering the following questions:
1. Can we successfully functionalize the bead surfaces with the primers?
2. What mechanism can we use to ensure the primers are available in solution when needed?
3. Can the surface-bound primers successfully hybridize target DNA?
4. Can we successfully create a microfluidic chip for bead encapsulation and ddLAMP?
5. How do we encapsulate only 1 bead per droplet without the use of very expensive tools?

Chapters 2 and 3 will address assay-based questions (1-3) above while chapters 4 and 5 will
address the questions bordering on microfluidic devices, ddLAMP and bead encapsulation
methods.
It is worth mentioning that in the course of this research, many interns and graduate students joined
the team and collaborated in various scales. My contribution to the work presented in each chapter
is highlighted below (Table 1).
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TABLE 1 My contributions throughout this thesis project
Chapter

Collaborators

1: Initial
Prototypes

My Contributions
Idealized and designed original microfluidic cartridge and device
prototypes

N/A

2: Bead
Functionalization
and Target
Hybridization

Dr.
Carsten
Schmidt, Dr.
Christiane
Geithe, Moira
Nakityo,
Vanessa Lin,
Corey Orndoff

Designed the fluidic handling, mixing, valve control system
Performed functionalization of carboxyl-beads with streptavidin and
biotinylated probes
Designed functional LAMP primers and probes with different labels
and functionalities used in the assay
Developed methods for imaging beads using the confocal microscope
Established methods for analyzing fluorescence micrographs using
ImageJ, and python
Designed FRET analytical methods for determining the efficiency of
indirect primer carrying efficiency of the probes
Created and validated the direct method of primer delivery
Idealized and modified chimeric primers used in the direct coupling
method
Created assay recipe and optimized protocols for simultaneous in situ
Rnase and BST polymerase activity in LAMP

Designed experiments to determine bead-primer carrying capacity
Developed method for testing for primer-DNA complexing
3: Primer-DNA
Modelled bead-primer carrying capacity using bead metadata and
Complexing &
manufacturer's certificate of analysis
Bead-Primer
Carrying
Madeline
Designed alternative methods for increasing the bead-primer carrying
Capacity
Zhang
capacity
Developed a co-flow microfluidic droplet generation system
Conceptualized, designed, fabricated and optimized prototypes of
microfluidic cartridges using 3d printing, soft lithography, laser
cutting, and resin casting
Validated methods for the generation of highly monodisperse picoliterscale droplet
Developed methods for and analyzed droplet micrographs using
ImageJ, Excel, Python, APEER, MIPAR, JMP, etc.
Established SOPs for the fabrication of microfluidic cartridges, and
troubleshooting of pumping systems
Optimized droplet generation chemistry for droplet mechanical and
thermal stability
4. Microfluidics
and Droplet
Corey Myers, Designed, fabricated, and optimized prototypes for dense bead
Generation
Derrick Sy
resuspension and mixing
Microbiology: developed media such as MRS broth for L. acidophilus
culturing, performed BSL-2 bacterial culturing, DNA extraction for
PCR and LAMP amplification
NA Amplification: conducted experiments on colorimetric LAMP,
droplet digital LAMP, designed primers and primer-quenchers,
performed troubleshooting on LAMP protocols, designed LNA oligos,
5. Others
N/A
modified LAMP master mix for various applications
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Chapter 2: Bead Functionalization with Target-specific Primers
The success of our platform largely depends on the efficiency of binding primers onto the beads
and the feasibility of primer-DNA hybridization upon mixing with the sample stream.
Functionalization of the beads (polyAn GmbH) with primers is preceded by the coating of the
beads with either streptavidin (when purchased beads are not streptavidin-positive) or
hybridization

probes

directly.

The

former

is

widely

achieved

via

1-Ethyl-3-(3-

dimethylaminopropyl)carbodiimide (EDC) cross-linking37 (figure 2.1a) while the later can be
achieved through azide-alkyne cycloaddition (Click-chemistry)38,39 (Fig2.1b) or streptavidinbiotin complexing40–42.

A

B

Fig. 2.1 Illustration Of EDC Chemistry (A)37 And Click Chemistry (B)43
Considering that the probes are covalently bound to the bead surface, click chemistry would be
better for our application, however, its yield is merely a fraction of primer-carrying capacity
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achieved using streptavidin-biotin coupling. Ideally, we need to maximize the primer-carrying
capacity of the beads, hence the choice.

Functionalization of Beads With Streptavidin
PMMA microbead suspension (PolyAn GmbH, 3D-carboxy functionalized beads) is centrifuged
at 10,000 RPM for 60 secs to remove the supernatant. The pelletized beads are washed using 200
µL of 0.1 M 2-(N-Morpholino)-ethanesulfonic acid buffer (MES pH 4.5, Sigma Aldrich) with
vortexing. On demand, 25mg EDC / mL MES buffer is reconstituted and mixed with the beads at
1200 RPM, 28oC for 30 minutes in Multitherm incubator (Benchmark Scientific, USA). After
incubation, the suspension is centrifuged at 10,000 RPM for 60 seconds and the supernatant is
removed. The pellets are washed with 200 µL of 0.05x phosphate-buffered saline, PBS, pH – 7.4
(Gibco) without vortexing. The washed beads are then mixed with 120 µg streptavidin
(Invitrogen)/ mL of PBS and incubated at 28oC for 4 hours at 1200 RPM. After incubation, the
bead suspension is centrifuged at 10,000 RPM for 60 secs and washed 3 times with 200 µL TBSTbuffer (50 mM Tris, 154 mM NaCl, 0.01% Tween-20, pH 7.4) without vortexing and resuspended
in 200 µL TBST.

Fig. 2.2. Confocal micrograph of transparent PMMA beads showing ligand fluorescence from
ATTO-633N fluorophore-labeled probes
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Functionalization of Streptavidin-Positive Beads With Biotinylated Oligos
Oligos with a stock concentration of 100 µM biotinylated probes and primers, and biotin and
fluorophore-labeled oligos were synthesized by IDT, USA – Table 2. 100 µL of the streptavidinpositive beads is mixed with 25 µL oligo (100 nM stock) and 15 µL TBST-buffer. The suspension
is incubated at room temperature for 1 hour with vigorous shaking at 1200 RPM. After incubation,
the supernatant is removed by centrifuging at 10, 000 RPM for 60 secs. The beads are then washed
3 times with 200 µL TBST without vortexing.

Table 2: Modified oligos used for the functionalization of streptavidin-positive beads
Primer
Ecoli_Cap_F_Bio
Ecoli_FIP_DZ2
Ecoli_FIP_DZ
Ecoli_FIP_DZ_Q

Sequence (5' -3')
/5ATTO633N/TAGTACCGGTACAATATATAT/3Bio/
ACC GGT ACT ACG GTT CGG TCC TCC AGT TAG TGT TTT CCC GAA ACC CGG TGA TCT
TGT ACC GGT ACT ACG GTT CGG TCC TCC AGT TAG TGT TTT CCC GAA ACC CGG TGA TCT
/5IAbRQ/TGTACCGGTACTACGGTTCGGTCCTCCAGTTAGTGTTTTCCCGAAACCCGGTGATCT

Green =main sequence, Red = fluorophores, Black = biotin, Purple = RNA moiety,
Orange = elongation sequence
Successful functionalization of the beads is assessed by fluorescence microscopy as shown in Fig.
2.2.

Indirect Bead Functionalization with Target-Specific Primers
It is worthy of note that the images shown in Fig 2.2 are streptavidin-positive beads functionalized
with biotin and fluorophore-labeled hybridization probes (Ecoli_Cap_F_Bio). A very critical
question after this step, therefore, was to determine the efficiency of hybridizing actual primers to
the probes as well as its merits and demerits. This method was dubbed indirect functionalization
method owing to the fact that the primers are not directly coupled onto the streptavidin-positive
beads.
To achieve this, Escherichia coli forward inner primers (FIP) were modified on the 5' end by
attaching a complementary sequence to the probe and labelled with a quencher.
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Fig. 2.3 Illustration of indirect primer coupling method and sensing using FRET.

Ideally, this method is preferred because it would save the cost of having a unique hybridization
probe per primer. It would also simplify the process of functionalization as it would be difficult to
control the ratio of FIP and BIP probe: F3 and B3 probe: LF and LB probes to be taken up by the
beads for successful LAMP amplification.
We assessed this method for primer-carrying efficiency using fluorescence resonance energy
transfer (FRET). In the protocol, biotin and fluorophore-labeled probes were used to functionalize
transparent PMMA beads following protocols discussed in the section above with 52.5 µL of bead
stock suspension. After functionalization, the suspension was divided into two ("Control" and
"FRET"). Aliquot of Ecoli_FIP_DZ_Q (quencher-labeled FIP) was added to the "FRET" batch to
make up 10 µM. The mixture was incubated at 28oC for 2 hours at 1200 RPM. After the
hybridization protocol, the beads were washed 5 times with TBST without vortexing and imaged
using confocal microscopy (Leica SP5) (Fig2.4A, B). Ligand fluorescence signals from the images
obtained were converted to numerical data using image J and visualized using python algorithm
(Fig 2.4C).
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Fig. 2.4 Bead functionalization using Method 1: Fluorescence images (A- control), (B- FRET)
and bar plots comparing the fluorescence signals from the control and FRET experiments

These showed incomplete FRET signifying inefficient hybridization of the primers to the probes.
In fact, a comparison of the RFU between the control and the experiment (FRET) batches showed
only 34.5 % loss in fluorescence due to quenching. This may have been as a result of steric
hinderance, rigorous wash step or inefficient hybridization protocol. However, an attempt at
optimizing the protocol by heating the mix to 70oC for 30 minutes at 1200 RPM and holding it at
room temperature for 2 hours at 1200 RPM yielded lower FRET efficiency with a 29.5% loss in
fluorescence (Fig. 2.5).

Fig 2.5 Bead functionalization using Method 2: Fluorescence images (A- control), (B- FRET)
and bar plots comparing the fluorescence signals from the control and FRET experiments
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This decline in FRET efficiency using the second protocol may have been as a result of increased
steric hinderance due to bead shrinkage at higher temperatures (Figure not included). It has been
shown that upon conditioning (subjecting the beads to high temperatures), the beads shrink, thus
compacting the density of the probes per the new surface area. Additionally, Holmberg et al.
showed that Streptavidin-biotin interactions can be reversibly broken by heating them to 70oC in
water44, thus partly suggesting a reason for the lower ligand fluorescence seen in Fig. 2.4 compared
to Fig. 2.5.
These may be reasons why hybridization of the primer may be more favorable at lower
temperatures and should be optimized with that in mind. Conclusively, we realized that while
indirect primer-bead coupling may be the best for thermal release into the reaction mix, it cannot
be exploited in delivering maximum primers to the sample.
The inefficiency of this method for our systems was further supported by the effect of the modified
primers on LAMP amplification.

Effect of Modified Primers on LAMP
Variants of the modified primers (without quencher and fluorophore) (Table 2) were used to
determine the feasibility of NA amplification with the modified primers. The figure below (Fig.
2.6) shows that compared to the unmodified primers (standard), the modified primers (6DZ) could
not be successfully used for amplification. The exact reason behind the failed amplifications with
the DZ primers is unclear, however, a couple of factors such as change in the thermodynamic
properties of the primers, and secondary structure formation, were suggested as possible reasons.
This phenomenon further necessitated the need for an alternative primer modification and delivery
method.
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Fig. 2.6 E. coli DNA LAMP to determine the feasibility of NA amplification with the modified
primers. 6DZ means that the six primers were modified (source: Vanessa Lin, Summer 2018)

Direct Primer Coupling Method
We showed previously that modification of primers by attaching an extra sequence interferes with
their functionality and that the use of the indirect primer-coupling method was largely inefficient.
Therefore, we considered the possibility of direct functionalization of the beads with primers. 3
major considerations of the new method are:
•

Increased efficiency in coupling the primers onto the beads,

•

Ease of releasing the primers on demand, and

•

Adaptability of the system to LAMP amplification.
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Fig 2.7 Direct coupling of primers to streptavidin-positive beads and release mechanism

In designing a method for the direct functionalization of the beads with choice primers, there are
only 2 options; directly modifying the 5' end of the primers with biotin or attaching a biotinylated
sequence that can be cleaved easily to release the active primers. A limitation of the first option
was that it required breakage of the biotin-streptavidin interaction, which, although can be
achieved by heating the amplification mix to at least 70 oC44, the optimal temperature for our assays
was at 68oC. Also there is no guarantee that all biotinylated primers would be released.
To determine the feasibility of option 2, we redesigned the E. coli primers to become chimeric
(Table 3), having sequences which could be easily cleaved by RNase enzyme as shown in Fig. 2.7

Table 3. Chimeric Primers for direct Primer-bead Coupling
Primer
Target Organism
Ecoli_FOP_RDZ
E. coli
Ecoli_BOP_RDZ
E. coli
Ecoli_LoopF_RDZ
E. coli
Ecoli_LoopB_RDZ
E. coli
Ecoli_FIP_RDZ
E. coli
Ecoli_BIP_RDZ
E. coli
F_Ec_FIP_RDZ_Bio
E. coli
F_Ec_FIP_RDZ
E. coli
20190829_F_Ec_RDZ_Bio
E. coli

Sequence (5' - 3')
rUrGrU rArCrC rGrGrU rArCrU rArUrU GGC GTT AAG TTG CAG GGT AT
rUrGrU rArCrC rGrGrU rArCrU rArUrU TCA CGA GGC GCT ACC TAA
rUrGrU rArCrC rGrGrU rArCrU rArUrU ACC TTC AAC CTG CCC ATG
rUrGrU rArCrC rGrGrU rArCrU rArUrU GTG AAA GGC CAA TCA AAC C
rUrGrU rArCrC rGrGrU rArCrU rArUrU CGG TTC GGT CCT CCA GTT AGT GTT TTC CCG AAA CCC GGT GAT CT
rUrGrU rArCrC rGrGrU rArCrU rArUrU TAG CGG ATG ACT TGT GGC TGG TTT TTC GGG GAG AAC CAG CTA TC
/5ATTO633N/rCrCrU rGrGrU rCCG GTT CGG TCC TCC AGT TAG TGT TTT CCC GAA ACC CGG TGA TCT rCrUrC rUrCrU rCrU/3Bio/
/5ATTO633N/rCrCrU rGrGrU rCCG GTT CGG TCC TCC AGT TAG TGT TTT CCC GAA ACC CGG TGA TCT rCrUrC rUrCrU rCrU
/5ATTO633N/CGG TTC GGT CCT CCA GTT AGT GTT TTC CCG AAA CCC GGT GAT CTrC rUrCrU rCrUrC rU/3Bio/
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Chimerism For Primer Delivery
To assess the feasibility of primer release using the chimeric primers, 46 µL of KOM1 (transparent
streptavidin-positive) beads (PolyAn) was centrifuged at 10,000 RPM for 60 seconds to remove
the suspending stock fluid. Into the bead pellets, 0.8 µL of 100 µM chimeric primer
(20190829_F_Ec_RDZ_Bio) from IDT was added and the volume was made up to 50 µL using
TBST. The mixture was incubated for 4 hours at 25oC before being washed 3 times using TBST.
After the wash step, the bead was resuspended in 50 µL TBST and 10 µL aliquot was removed for
pre-amplification microscopy (Fig 2.8a). The remaining bead suspension was centrifuged and
drained of the supernatant for use in LAMP.
To enhance digestion of the RNA moiety, the LAMP master mix for the bead-based LAMP
contained 300 mM NaCl, 1x TE buffer (Usb - 10mM Tris + 1mM EDTA, pH 7.4) and 2% v/v
5000 U/ mL Rnase A/T1 (ThermoFisher), FIP-carrying beads, and All-but-FIP(ABF) primer mix
(1.6 µM BIP, 0.2 µM each of F3 and B3, 0.4 µM each of LF and LB). Two controls were set up
alongside this experiment, with one containing standard LAMP mix and reagents and the other
containing unbound chimeric FIP, ABF, and equal concentrations of TE, NaCl, and RAT1-E as
the bead-based LAMP. The LAMP setup was incubated at 68oC using Light Cycler 96 (Roche) for
1 hour.
As shown below, of the three experiments, only the bead-based LAMP did not amplify
successfully. Interestingly, however, post-amplification microscopic analysis of the functionalized
beads showed successful digestion of the RNA moiety signified by the absence of ligand
fluorescence (dark pictures) around the beads (compared to Fig 2.8a).
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Fig 2.8. Use of chimeric primers as a primer delivery system. A. Pre-amplification fluorescence
imaging of the beads functionalized with chimeric primers. B. Post-amplification fluorescence
imaging of the beads from the bead-based LAMP C. Amplification of E. coli DNA using normal
primers, ex-situ digested chimeric FIP (mFIP) + ABF, and Bead-delivered FIP (BLAMP).

Although the bulk amplification experiment failed, the results showed that digestion of the RNA
moiety to release the primers can run at the same physical conditions (e.g. temperature) as actual
amplification.
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Optimization of In-situ RNA Digestion and Simultaneous Amplification
Further experiments showed that the addition of TE and NaCl are implicated in the inhibition of
LAMP (Fig. 2.9 A). Hence, we optimized the primer release system using non-fluorophore-labeled
and non-biotin-labeled chimeric primers. The protocol was optimized such that digestion would
not require the addition of NaCl and TE buffer.

Fig 2.9 Amplification of E. coli DNA using chimeric primers and standard primers. A: titration of
different percentages of recommended RAT1-E digestion excipients. Full Option refers to 300mM
NaCl + 1x TE (10mM Tris + 1mM EDTA, pH 7.4) B: Optimization of in-situ chimeric primer
treatment using only 2% RAT1-E
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In developing the protocol, all 6 LAMP primers for E. coli amplification were chimeric. During
this assay design, we learned that unlike primers modified using a DNA sequence, the chimeric
primers were able to amplify target DNA albeit slower (Fig. 2.9 A: Chimeric – Nil DNA) and the
addition of more than 2% RAT1-E inhibited the amplification (Fig 2.9 B: Chimeric + 4% RAT1E DNA). In the end, all that was needed for successful chimeric primer digestion and DNA
amplification using the 6 chimeric primers was the addition of 2% v/v RAT1-E into the master
mix.

Unfortunately, the optimization of the chimeric primer digestion (primer release mechanism) for
integration into LAMP did not lead to successful bulk LAMP amplification using bead-delivered
FIP primers. A major re-occurrence, however, was a decrease in the time to positive reaction of
the chimeric system compared to the normal primers. This raises the question, is it possible we
made LAMP more sensitive? Also, what was directly responsible for the phenomenon, 2% RAT1E, the FIP-RDZ primers, the 6RDZ primers or a combination of factors?

Conclusion
We successfully developed a system for the functionalization of the microbeads with streptavidin
and primers using EDC chemistry and streptavidin-biotin interactions respectively. We also
developed a mechanism that could ensure the on-demand release of primers by exploiting RNA
chemistry.
Considering the failure of bulk bead-based amplification using the developed systems, a critical
question therefore comes up; are the beads capable of delivering enough primers for successful
amplification? In addition to this question, there is the need to determine the feasibility of beadprimer-DNA complexing – a critical step that would ensure that primers hybridize to their specific
targets during mixing. These are addressed in chapter 3.
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Chapter 3: Primer-DNA Complexing and Bead Primer-Carrying
Capacity
Bead-Primer Carrying Capacity, BPCC
The bead primer-carrying capacity (BPCC) is very critical in determining the final volume of the
reaction mix. Optimal reaction conditions of LAMP require a final primer concentration of 4.4
µM, since we intend using beads with an average diameter of 20 µm, it is important that the beads
are able to deliver enough primers to droplets with a minimum diameter of 30 µm (~14 pL).
Considering that streptavidin is a tetramer, in determining the BPCC, we estimated for both the
best- and worst-case scenario. The best-case scenario being that each molecule of streptavidin is
able to couple 4 molecules of biotin, while the worst-case scenario represents a condition in which
each streptavidin molecule is only able to couple 1 biotinylated primer. This calculation, however,
is only feasible if the streptavidin loading of the beads are known, this is readily obtained from
PolyAn GmbH for streptavidin-positive beads. Although this can be determined for beads which
were functionalized in-house with streptavidin using similar methods as that of Dorgan et al40, we
did not pursue it. For the purpose of experimentation, we assumed similar capacity/ efficiency as
that reported by PolyAn.
In determining the volume of droplet required for the BPCC to equal optimal primer concentration,
we assumed the worst-case scenario and the calculation is done following Table 4.
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Table 4. Bead Primer-carrying Capacity Calculator

TP190214KOM1
E

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

Bead Density
Mean Bead Diameter
∏
Bead volume

Mass Per Bead
Number of beads per gram
SA Loading Per Bead
# of beads per 10uL of stock
Vol. per vial
% Solid (KOM1)
Actual Vol of Beads in Vial
# Beads per vial
Beads per 10 µL @1% solid
Biotin/ Oligo per Bead
Biotin/ Oligo per Bead
For beads in 10uL Stock
For beads in 10uL Stock

SA Loading

10.5 nanomol/g beads

F

Bead Parameters
1.18 g/cm³
21.5 µm
3.141592654
5203.720981 µm³
5.20372E-06 µL
5.20372E-08 cm³
6.14039E-08 g
16285608.51 beads
6.44741E-07 nanomol SA per bead
19217.01804 Beads/10uL of stock.
Vial Parameters
1.5 mL
1%
15 µL
2.88E+06 Beads
19217.01804 Beads/ 10 µL
Oligo Parameters
2.57896E-06 nanomol oligo/ bead
6.44741E-07 nanomol oligo/ bead
0.04956 Nanomol oligo
0.01239 Nanomol oligo

PI()
(4/3)*F3*(F2/2)^3
F4*1e-9

or 3.823e-9 cm3

F12*F13*1000
F15/F5
(10/F5)*F13
Considering 100% efficiency
Considering 25% efficiency
Considering 100% efficiency
Considering 25% efficiency

MAX oligo carrying capacity per Bead
Min oligo carrying capacity per Bead
MAX oligo carrying Capacity/ 10 uL stock
MIN oligo carrying Capacity/ 10 uL stock

Using the above table, we determined that at 25% efficiency (worst-case scenario), each 21.5 µm
bead is capable of delivering 6.45E-07 nmol oligo per reaction (6.45E-05 µM per 10 µl LAMP
reaction). Thus, to deliver 4.4 µM of primers per 10 µL of LAMP reaction, we would require
~68,217 beads with an average diameter of 21.5 µm. This amounts to ~106 µL of the bead stock
(1.5 mL) for 3 replicates of the bulk amplification. As a surrogate to determine the accuracy of the
estimates, we developed protocols for bulk NA amplification using bead-delivered primers using
both indirect and direct methods.

In a protocol involving indirect primer-coupling onto beads, we functionalized 129 µL of 21.5 µm
streptavidin-positive beads with RDZ primers and probes. Equimolar concentrations (10 µM) RDZ
primers and Ecoli_Cap_F_Bio probes were incubated by heating to 95oC at 1200 RPM. This
allows for the hybridization of the primers to the probes. The probe-primer mix is then used to
functionalize the beads at room temperature for 2 hours at 1200 RPM. After incubation, the
mixture was stored in ice prior to use in amplification. Understandably, bead-based amplification
using this protocol failed (Fig. 3.1) due to inefficient primer delivery by the beads using the indirect
primer hybridization method as shown earlier via incomplete FRET.
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Using the direct method, 58.76 µL of streptavidin-positive beads (21.5µm) was functionalized
with F_Ec_FIP_RDZ_Bio (biotinylated E. coli FIP primer). These were considered enough to
deliver 1.6 µM FIP primers into the reaction mix. A final concentration of 1.6 µM of FIP was used
to functionalize the beads at room temperature and 1200 RPM. After functionalization, the beads
were washed and resuspended in nuclease-free water to remove aliquots for microscopy (before
amplification). The bead suspension was then centrifuged at 10,000 RPM and 19.26 µL of the
supernatant was removed, leaving behind 20.8 µL. The remaining volume was used to resuspend
the beads, distribute the beads into 2 empty wells (10.4 µL each) prior to reducing their volumes
0.74 µL after centrifugation. Other reagents, including ABF (all-but-FIP) primers were added
exogenously. This assay also failed and could be due to inaccurate estimation of the carrying
capacity of the beads which would result to the delivery of suboptimal FIP primer concentration
in the reaction mix.

Fig. 3.1 Amplification using bead-bound FIP (direct, indirect), biotinylated chimeric FIP primers
(mFIP) and standard primers (Normal).

Experimental Determination of BPCC
In this experiment, 16 µL (~19,200 beads) of KOM1 beads was functionalized using biotin and
fluorophore-labelled probes at varying concentrations. Earlier discussed protocols for bead
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functionalization were applied, after which confocal microscopy was used to capture the bead
ligand fluorescence. A pictorial map of the steps used in analyzing the beads for fluorescence is
shown in Fig. 3.2.
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Fig 3.2 A: Pictorial illustration of bead ligand fluorescence determination

34

Fig 3.2 B: Pictorial illustration of bead ligand fluorescence determination
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The results of the experiment (Fig. 3.3) showed that the beads were saturated at 0.1 µM probe
loading. Thus, implying that ~19000 beads are only capable of delivering 1E-6 µmoles of primers
in a 10 uL LAMP reaction. In order to deliver 1.6 µM FIP concentration required for bulk LAMP,
we would require ~304,000 beads (125 uL of the KOM 1 stock). Given that the volume of each
bead is 4.19E-6 µL, at 74% packing efficiency, the beads alone would take up ~26 % of the 10 µL
reaction volume space. This may not really be a problem but have not been tested. A major
consideration is that we would need 5 folds more stock bead volume than what we used in previous
experiments in order to test the feasibility of the bulk LAMP reaction with the beads.

Fig. 3.3 Titrimetric determination of Bead-primer-carrying capacity, BPCC

We considered the possibility of improving the BPCC beyond what is obtainable traditionally with
the beads. Two possibilities were opted for; 1. Using dendrimers to ensure multiplicity of the
primer density around each bead; and the use of primer hinging oligos, PHO.
The PHO is by design, short RNA moieties capable of linking the 5' and the 3' ends of 2 different
primers together (as shown in Fig. 3.4A). As shown in Fig 3.4B, we could not determine the
success of the procedure from gel electrophoresis. This could be as a result of degradation of the
RNA moieties or inability of the PHOs to hinge the primers.
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Fig. 3.4. A: Illustration of the Dendrimeric (left) and PHO Systems (Right) B: Gel
Electrophoresis to Determine the Feasibility of Hinging the Primers using PHO.
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PRIMER-DNA COMPLEXING
A major unit process in our platform is designed to exploit primer-DNA hybridization chemistry
such that bead-bound FIP primers would anneal to their specific genomic DNA targets.
As illustrated in Fig. 3.5, to assess the feasibility of this, a 100 DNA copies/ µL dilution of E. coli
genomic DNA was made and divided into 2 vials (S1 and S2). 50 µL of S1 was added to pellets
of PolyAn KOM1 beads (~1.92E+04, 20 µm beads) functionalized with biotinylated E. coli FIP
chimeric primers (F_Ec_FIP_RDZ_Bio) using the direct method. The mixture was heated to 95oC
for 1 minute, then held at 15oC for 30 minutes using the Multitherm instrument. After incubation,
the tube is allowed to sit for 3 minutes to allow the beads to settle. Albeit without beads, S2 was
put through the same processes as S1 in order to ensure that any differences between S1 and S2
were as a result of primer-DNA coupling.
Supernatant from S1 was used to prepare PCR mix at a final concentration of 10 copies/ µL
(assuming the DNA concentration in the suspension is not reduced via bead-primer-DNA
coupling). The same was done for S2. The result of the PCR from both S1 and S2 are shown
below (Fig. 3.6) with a Cq difference of 4.06 minutes translating to the uptake of 450 copies of
DNA out of 500 in S1.

Fig 3.5 Illustration of the Bead-Primer-DNA Complexing Experiment
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A similar process was carried out using ~35.9E+06, 2.2 µm beads, however, the starting
concentration of S1 and S2 is 1.94E+4 copies/ µL (nanoquant determination) E. coli gDNA. From
S2 dilutions up to 970.5 copies/ µL E. coli gDNA were made and amplified alongside the test. The
qPCR test results show a delayed amplification of the test experiment (with beads) by ~1.5 minutes
compared to the starting concentration of S2 (Fig. 3.6B). From standard curve calculations, this
translates to a ~23% reduction in the DNA concentration showing an uptake of 256 copies of DNA.
Both experiments present a successful proof of the concept of using the bead-bound FIP primers
to capture specific genomic DNA from a sample stream.

# 𝑜𝑓 𝑐𝑜𝑝𝑖𝑒𝑠 (𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠) =

𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
)
𝑚𝑜𝑙𝑒
𝑔
𝑛𝑔
9
(𝑁∗660
)∗10 ( )
𝑚𝑜𝑙
𝑔

𝑋(𝑛𝑔)∗6.0221∗1023 (

equation 2

Where X = amount of amplicons (g), N = length of ds DNA (3.1*10^9 Da)45, 660 g/ mole = Avg. mass of 1bp of dsDNA
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Fig. 3.6 Experiments to determine if FIP-bound primers are capable of carrying target DNA. A: 20 µm beads were used with a starting
concentration of 10 copies/ µL. B. Repeat of the FIP-DNA hybridization experiment using 2.2 µm beads and a starting concentration of
2.94E+04 copies/ µL (inset: melt curve justifying that NTC fluorescence signals are due to secondary structure from LAMP's FIP used
as PCR forward primer)
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Conclusion and Next Step
Experimental BPCC showed revealed that a very large number of beads are needed to achieve bulk
amplifications using bead-borne FIP, and much more for the rest of the primers. Considering the
cost implication of this, it would be worthwhile to switch to droplet-based testing regimes.

Using the same theoretical BPCC estimation from previous experiments, we determined that the
minimum volume of droplets required to equate the BPCC to 4.4 µm of primers in a droplet is
~150 pL. This requirement necessitated the development of protocols for the generation of
picoliter-scale droplets. It is worthy of note that these estimations were not made using the
theoretical methods ignoring the experimentally derived values. Rather, both the theoretical
BPCC-based experiments and the microfluidics methods discussed in Chapter 4 happened within
the same time frame. The developed methods can also be adapted to the experimentally derived
values on demand.
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Chapter 4: Microfluidics and Droplet Generation
Why Embrace Microfluidics
Cheng et al46 showed the possibility of LAMP using bead-bound FIP in droplets generated via
high frequency emulsion generation. While their methods seem to predicate ours, they failed in
optimizing the efficiency of bead encapsulation. Thus, out of 8.4E+06 beads, only about 12% had
single beads. Their method was also limited by the random distribution of the exogenous primers.
These may have led to their report of only ~10% of single bead-containing droplets being positive
for amplification. More so, such bead encapsulation methods are not ideal for multiplexing and
leads to excessive loss of beads, primers, and reaction efficiency.
To achieve better results, we needed to make concerted efforts to ensure more efficiency in the
encapsulation of the beads hence the need for the development of microfluidic platforms as
discussed in this chapter.

Microfluidic Device Fabrication
To the best of our knowledge, the generation of highly monodisperse picoliter-scale droplets have
been mostly linked to the use of very elaborate and expensive methods. For example, many
researchers47–56 have generated picoliter and femtoliter-scale droplets using devices fabricated
with techniques such as photolithography,

micromachining, laser, and wet etching,

pyroelectrodynamism57, inkjet printing58, etc.
We required an easy, rapid method for developing microfluidic prototype cartridges which could
serve as an alternative to photolithography. Zhang et al.59 reported the possibility of generating 50
µm droplets using 3d printed cartridges. Other researchers59–63 have also shown the application of
3d printing for the generation of droplets but not in the scale reported by Zhang et al. To the best
of our knowledge, Zhang's report is debatable as they were only able to achieve a minimum Ddrop
~0.6 using Dtubing of 177 µm (Ddrop = Ddiameter/Dtubing). This places their smallest droplet diameter
at ~106 µm. More so, in order to achieve this, a very low ratio of the volumetric flow rates of the
dispersed phase to the continuous phase (Qd/ Qc << 0.015) was employed, a major cause of
excessive waste of the continuous phase medium. Thus, while the use of 3d printing has been well
reported for droplet microfluidics, proof of the generation of highly monodisperse picoliter-scale
droplets are not published.
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We investigated dropwise and co-flow regime for droplet generation, as expected, these yielded
droplets which were much larger than we desired (Fig. 4.1A). Other methods such as 3D printing
- using stereolithography (SLA) and fused filament fabrication, and bonded laser cut acrylic
materials were assessed. SLA printing of master molds61 showed the most promise with respect to
simplicity, turnaround time, and ease of replication.
To exploit this, 3D models of the master molds were designed using Solidworks CAD software
(Dassault Systems) to have flow channel dimensions of 100 µm x 100 µm and inlet/ outlet ports
of 750 µm (Fig 4.1B). Subsequently, the stereolithography files were prepared for 3D printing by
orienting them at an angle of 45o, avoiding overhangs, using Form Labs' Preform software. The
models were then printed using Form3 SLA 3D printer (Form Labs) on clear resin (v4 FLGPCL04) at a layer thickness of 25µm. The printed master molds were thoroughly cleaned with
isopropyl alcohol to remove excess resin, UV-cured for 30 minutes, and each filled with 3g of predegassed mixture of polydimethyl siloxane, PDMS – SYLGARD silicone elastomer 184 and
SYLGARD silicone elastomer 184 curing agent (Dow Corning) combined at 10:1 w/w ratio
respectively. The setup was degassed again in Cole Parmer Diblock oven and cured at 65oC for 45
minutes. Once cured, the PDMS was gently peeled from the master mold and bonded onto
microscope slides after surface activation using flame treatment as an alternative to oxygen plasma
bonding64 and placed in 85oC oven overnight to allow the PDMS to harden.
After fabrication, the cartridges are examined for binding strength of the PDMS by gently prying
at them and also checked for channel dimensions under the microscope. A ± 10% tolerance is
allowed for the channel widths measured from micrographs prior to tube attachment. In
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Fig. 4.1 A. droplet generation using co-flow and dropwise methods.
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Fig. 4.1 B. Fabrication of PDMS-based microfluidic Chips using 3D printed molds

Pitfalls Of 3D Fabrication of Microfluidic Cartridges
While making microfluidic cartridges using 3D printing, we identified several unpublished pitfalls
attendant to the method. We characterize these as procedural and equipment dependent.

Equipment-dependent Pitfalls
One of the major challenges attendant to using 3D printing for microfluidics is the limitation of
the printer's resolution. We find that despite the advancements in 3D printing, especially desktop
SLA printers, it is incredibly difficult to print channels with width less than 50 µm. More so,
printing of master molds at higher resolutions (e.g. 25 µm layer height) forces the printer to run
for prolonged hours, thus, giving room for misaligned prints. This misalignment creates micro
channels in the molded PDMS thereby causing leakage in the final cartridge.
As experienced with the Form 2 and Form 3 (Form Labs) 3D printer, orientation of the 3D models
also determines if the base of the molds would have crosshatches or a smooth finish. This is evident
while comparing vertically oriented and angled 3D prints.
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Another major consequence of the printer limitations is the difficulty in printing well-defined 90o
edges. This impacts flow focusing more as there is always a characteristic curvature at the flow
junction. This curvature slightly alters the principal flow focusing pattern seen on
photolithography-based flow focusing systems. Although this principle has not been further
experimented on, it would be worthwhile to simulate the principle using ANSYS Fluent.

Procedural Pitfalls
As shown in Fig 4.2a, Batch-to-batch variations in channel dimensions is a major limitation of this
system. This often comes from the post-print cleaning of master molds. Inadequately cleaned edges
(especially around the flow channels) and other dead spaces) may lead to increased channel
dimensions once the left-over SLA printer resin cures. More so, if the base of the mold is not
stripped of the residual resin, it causes the base to be irregular and once imprinted onto the PDMS,
prevents it from binding strongly onto the glass slides. This gives the PDMS a frosty appearance
as shown in Fig. 4.2b.
It is common occurrence for PDMS to be trapped in the vertices of the printed mold. If the cured
PDMS is not peeled gently from the mold, there is always a risk of losing the channel wall
definitions, which, in turn would affect the channel dimensions. More so, the idea behind the use
of a 3D printed mold is to encourage usability of the molds. However, with the gradual and
continuous deposition of tiny chips of PDMS, the channel dimensions continuously increase with
continued use. In addition to these, if the PDMS is not completely cured, attempts to peel it off the
mold creates irregularities in the channel dimension and definition. In most cases, the channel may
be completely sealed, tapered or shrunk by efforts to bind the molded PDMS on the glass.
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Fig. 4.2 A. Batch to Batch Variations in Channel Dimensions B. Other results of procedural
pitfalls

Picoliter-Scale Droplet Generation
Droplets were generated using the optimized flow-focusing microfluidic cartridges fabricated
using 3d-printed molds and soft lithography. The continuous phase consisting of mineral oil
(Sigma Aldrich -M3516-1L), 0.1 wt% Triton X-100 (Fisher Biotech), and 3 wt% ABIL EM 90
(Evonik, Germany) was pumped at different flow rates, Qo = [20, 25, 50, 75, 100] µL/min. Both
the dispersed and continuous phases were infused using two syringe pumps (KD Scientific). The
cartridge was set on an optical microscope (Omax) for event monitoring by recording midhighspeed (960 fps) videos of droplet generation using Samsung Galaxy Note 10. The videos were
used to study fluidic behaviors and other events while the droplets are collected for imaging.
Micrograph images of the droplets were taken using confocal microscopy (Leica SP5) and their
planar diameters were determined using Image J. The volumes of the droplets were determined
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manually by calculating their spherical volumes. To ensure consistency and reproducibility of the
droplet generation system, the droplet generation and analysis experiments were replicated at
different dates, using different cartridges. These are shown in Fig. 4.3 A – B.

Fig 4.3 A. Left: Figure showing response of the droplet diameter to change in the volumetric flow
rate of the continuous phase (oil). For these experiments, the volumetric flow rate of the dispersed
phase (water) was kept constant at 1 µL/ minute. Middle: Micrograph of the droplets obtained
during the experiment Right: Droplet diameter distribution per flow condition. This also shows the
polydispersity index of the droplets (CV) values. B Top: Visualization of Droplet diameter:
Droplet volume and diameter distribution at different days and using different cartridges
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Droplet-Based Loop-Mediated Isothermal Amplification for DNA Amplification
Using the Fabricated Cartridge
To verify the usability of the developed cartridges in molecular applications, digital loop-mediated
isothermal amplification, LAMP, for the detection of Lactobacillus acidophilus was performed. L.
acidophilus obtained from MicroKwik vials (Carolina.com) was cultured in de Man, Rogosa and
Sharpe (MRS) agar formulated in-house. Lucigen's DNA extraction kit (Quick Extraction) was
used for DNA extraction from the colonies. The precise quantification of the extracted genomic
DNA was measured using Nanodrop One (ThermoFisher Scientific).
Droplet Digital LAMP Assay, ddLAMP
For a first test run of the performance of our unit in ddLAMP, we amplified a final concentration
of 20 ng/ mL of Lambda DNA using Calcein-MnCl2 mix (final concentration: Calcein 2500 µM,
MnCl2 - 75mM) as non-specific fluorescent dye. The droplets were formed using the same oil mix
described earlier and pumped with syringe pumps (Harvard Apparatus 22). For this experiment,
cartridge with dimensions (H xW) of 100 µm x 50 µm was used. Bulk amplification of the same
set up was set up for process control (Fig. 4.4 a).
For the droplets, both the (no template controls) NTCs and test droplets were amplified. Confocal
micrographs (Fig. 4.4 c) obtained from the amplified droplets were analyzed for fluorescence using
earlier discussed methods using ImageJ. To establish a threshold, the mean NTC relative
fluorescence units (RFU) After amplification + 3*standard deviation was used. The obtained data
was visualized (Fig. 4.4 b) using python scripting to quantify the positive droplets.

Analysis of the data showed that 20% of the droplets generated from the positive sample stream
were positive after amplification. With Lambda DNA length as 48502 bp and an average droplet
volume of 98 pL (0.38 copies/ pL), based on Poisson, we would expect all the droplets to be
positive. Principally, we calculated the actual concentration utilized in the amplification as we
believed this was as a result of loss of DNA to the walls of the tubing. Hence to avoid this, we
resorted to flushing the tubing and cartridge with 5mM bovine serum albumin (BSA) prior to
ddLAMP run.
From the analyzed data, we estimated that the actual DNA concentration used (or that made it into
the droplets) for amplification was 2.4 copies/ mL (2.43E-05 copies/ pL)
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Fig 4.4 A. Bulk amplification of Lambda DNA used as a process control for the digital droplet
LAMP B. Dot plot showing fluorescence signals from each distinct droplet used in ddLAMP
C. Confocal micrograph showing the fluorescence signals of the droplets before (left) and after
amplification (after).

Upon optimizing the ddLAMP protocols, a repeat using L. acidophilus was initiated. LAMP
Master mix containing 1x isothermal amplification buffer, 8mM total of MgSO4, 1.4 mM dNTPs,
320 U/ mL Bst 2.0 WarmStart polymerase, primer mix (1.6 µM each of FIP and BIP, 0.2 µM each
of F3 and B3, 0.4 µM each of LF and LB), 1x SybrGreen was diluted with varying DNA
concentrations. These dilutions yield 0, 1.56, 3.76, 7.48, and 60.47 DNA copies/ droplet coinciding
with approx. 0, 25, 50, 75 and 100% positive droplet distributions per Poisson prediction. Before
ddLAMP, 40 µL aliquots of each dilution were distributed into 4 tubes (Roche), and amplified at
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68oC for 60 minutes using Roche LC 96. All LAMP reagents were purchased from New England
Biolabs (NEB) while the primers (Table 5) were designed in-house to target L. acidophilus 16S
rRNA.

Table 5 Lactobacillus acidophilus primers
Primer
Lacid_FOP_TA
Lacid_BOP_TA
Lacid_FIP_TA
Lacid_BIP_TA
Lacid_LoopF_TA
Lacid_LoopB_TA

Sequence (5' - 3')
TAA AGC GAG CGC AGG C
CCT CAG CGT CAG TTG C
CTG CAC TCA AGA AAA ACA GTT TCC GAG TCT GAT GTG AAA GCC CTC
AAG AGG AGA GTG GAA CTC CAT GTG AGA CCA GAG AGC CGC CTT
GCA GTT CCT CGG TTA AGC C
ATG CGT AGA TAT ATG GAA GAA CAC C

Droplets from the microfluidic cartridges was collected in amber sepcap vials and incubated at
68oC for 60 minutes using Multitherm incubator (Benchmark). Upon completion of the
amplification step, the droplets were imaged using Leica SP5 confocal microscope and analyzed
using image J to determine droplet RFU which are represented in Fig. 4.5.
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Fig.4.5.ABulkamplificationofdilutionsusingRocheLC96B.FigureshowingcorrelationbetweenPoissonpredictedpositivedropletand
experimentaldata.C.Solid lineshowsexpectedfractionofpositivedroplets andhowexperimentaldatafollows/deviates fromconventional
expectations.D. Post-amplificationmicrographsofdropletsandthedistributionof thedropletsaroundthethreshold.Thresholdwas
determinedasMeanRFU(0CPD)+3*St.Dev(0CPD)
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Chapter 5. Encapsulation of Beads In Droplets
Interests in using microparticles as delivery systems in various technologies have been widely
researched, especially in combination with microdroplets for biological applications65–69. This is,
in part, due to the high surface-to-volume ratio and the ease of immobilizing biorecognition
molecules on them as well as the potential for compartmentalized single-molecule assays70–72.
Single particle encapsulation in droplets, however, face two major challenges:
•

Sedimentation due to particle density69, and

•

Mechanistic single particle encapsulation73,74

Offsetting Particle Density
Particle density poses a challenge when loading microparticles into encapsulation devices
because the higher density particles sediment in the syringe and delivery tubing, causing
nonhomogeneous distribution of microparticles in droplets. This, however can be solved by the
dissipation of the beads density by suspending them in denser fluids such as glycerol69. However,
such fluids may not be compatible with the intended bio-application. For example, many
applications use beads to separate biomolecules (proteins or nucleic acids)75,76, and in other
downstream processes, such as nucleic acid amplification or detection68,77–80. The beads could be
evenly distributed by matching the surrounding solution density with the bead density. However,
increasing the buoyancy of microbeads by suspending them in such fluids (e.g. glycerol), which
has a similar density as the microbeads (for example, 50% v/v glycerol – 50% less than what is
required to improve buoyancy) inhibits LAMP, thereby defeating the purpose of the beads, Fig.
5.1.
To circumvent this challenge attendant to dense beads, many researchers68,72,81,82 used elastic
packed/ gel beads which ensured a binary distribution of beads in the droplets without the
challenges attendant to non-gel beads. This method is, however, time-consuming, requiring a
particle velocity of ~50 µm/ hour73 or ~12 µL/ min to achieve single-particle encapsulation.
More so, the use of smaller beads and channels with aspect ratios close to the particle diameter
are other methods to ensure one particle per droplet. However, considering that these beads are
hard-shelled, their packing density may prohibit the possibility of closed packing. Also, smaller
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beads may not carry enough binding capacity for the biomolecule of interest; fabricating < 50
µm channels, from our experience is challenging and may mostly be feasible via sophisticated
methods such as photolithography.
Price et al69 presented a potentially simple solution by exploiting the sedimentation potential of
the beads using a hopper system. They, however, showed that it took 0.8 h (17 µm Tetangel resin
beads) and 3.8 h (2.8 µm magnetic beads) into bead introduction before achieving single bead
encapsulation. Kim et al65 successfully developed a pneumatic system which is capable of
trapping and releasing beads, thus creating a deterministic encapsulation of a defined number of
beads per droplet. This system, however, is not simple to develop, thus, unfit for low-cost pointof-care devices and for our application.
Our goal is to present a simple, easy-to-develop solution to working with non-gel beads towards
a more simplistic method of single bead encapsulation. In our system, we are confronted with
challenges which must be taken care of.
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Fig. 5.1. Denser fluids, such as glycerol may improve bead buoyancy but inhibit intended
application (LAMP) Bead Density = 1.18 g/ cm3, Glycerol Density = 1.26 g/ cm3. To offset the
bead density, there is need to suspend the beads in 100% glycerol. What is the effect of such high
concentration of glycerol in LAMP

Another simple

method is to vertically orient the syringe pump while keeping the beads

suspended by mechanical agitation. Given the ease of adopting this solution, we embraced it for
our system in order to improve the efficiency of bead/ particle encapsulation.

Bead Suspension Via Mechanical Agitation
To prevent loss of beads due to sedimentation in the flow tubing (Fig. 5.2 A) and in the syringe,
we used a vertically actuated syringe pump system such that the content of the syringe is pumped
directly into the encapsulation cartridge. To prevent bead sedimentation in the syringe, a magnetic
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stir bar inside the syringe is externally controlled using magnets on a DC motor (Fig. 5.2). Due to
the low torque of the stir bar, convective mixing was inefficient.

Fig. 5.2 Top Left Beads are lost in flow tubing due to sedimentation. Top Right Using low torque
mixing regime does not effectively suspend the beads leading to the encapsulation of multiple
beads (Bottom)

As an upgrade to the mixing and suspension of the beads, we designed and developed another
simple system which uses a 4.5 Volts DC motor fixed inside a syringe to achieve mixing of the
syringe content at higher torque.
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Design of The Mixing System
A rotary device is used to make a 9mm hole in a 3mL syringe between the outlet and the 0.5 mL
volume mark. Vibratory motor repurposed from a bead-beating sample preparation module
(Claremont Bio) is inserted through the hole and glued using cold weld steel-reinforced epoxy (JB
Weld). To ensure all crevices and air space at the motor-syringe interface are plugged, the syringe
is capped, and a vacuum is created using the syringe plunger. When completely dried (48 – 72
hours), the mixers are tested using a 4.5V battery pack before use in the actual experiment.

During an experiment, the bead suspension is allowed to mix for about 5 minutes prior to
dispensation to allow for an even mixture. As shown in Fig. 5.3, this led to an improvement in the
delivery of the beads into the cartridge, especially, in combination with vertical pumping of the
beads.

Fig 5.3 Improved bead distribution in droplets due to mixing and better bead suspension
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Single Bead Encapsulation
In principle, as particles move in microfluidic systems, they are acted upon by two major forces
due to inertia which cause them to follow a streamline closest to their center of mass
(equilibrium position). An implication of this system is a random arrangement of particles
relative to each other. Particles could move side by side or one on top of another, etc. This is a
major concern in single particle encapsulation which often results in Poisson distribution of the
particles. We hypothesize that in order to achieve single particle encapsulation without the use of
complex equipment and technologies, there is a need to create a single streamline for the
particles thus forcing them to flow in single file. It is also important to control the spacing
between the particles in order to avoid the waste of materials caused by the encapsulation of
empty droplets. One method of achieving this is by making channels whose aspect ratio is close
to the diameter of the particles of interest. Unfortunately, using our chosen method, 3D printing,
printing features close to 20 µm is incredibly difficult. An alternative method is the use
hydrodynamic focusing.
Hydrodynamic Focusing in Microfluidic Systems
The majority of microfluidic systems are 2-dimensional, leading to the squeezing of the
dispersive fluid flow channel on both sides by sheath fluid83,84. While this squeeze reduces the
width of this channel and changes the flow characteristics of the particles, it increases the aspect
ratio of the channels because of its inability to focus the sample flow in the vertical direction84.
Although promising, these methods increase the overall volumetric flow rate of the sample
stream, thus, leading to the creation of large droplets unless a very high flowrate of oil is used.
While this flow regime is not the most preferred, one of its primary goals is to control the
spacing between the particles; this can be achieved using the following flow characteristics.
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Fig 5.4 Illustration of Hydrodynamic focusing and flow cell designed for its achievement

𝑸𝒕𝒐𝒕𝒂𝒍 = 𝑽 ∗ 𝑨 , 𝑤ℎ𝑒𝑟𝑒 𝐴 = 𝑐𝑟𝑜𝑠𝑠 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑟𝑒𝑎, 𝑄 = 𝑣𝑜𝑙𝑢𝑚𝑒𝑡𝑟𝑖𝑐 𝑓𝑙𝑜𝑤 𝑟𝑎𝑡𝑒,
𝑉 = 𝑓𝑙𝑜𝑤 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦
𝐴=

𝜋𝑑2 2
4

; where 𝑑2 = 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 + 𝑥 (𝑎𝑙𝑙𝑜𝑤𝑎𝑛𝑐𝑒)

𝑄𝑡𝑜𝑡𝑎𝑙 = 𝑄𝑠ℎ𝑒𝑎𝑡ℎ + 𝑄𝑠𝑎𝑚𝑝𝑙𝑒
𝑄𝑠ℎ𝑒𝑎𝑡ℎ = 0.125 ∗ 𝑉𝑠𝑎𝑚𝑝𝑙𝑒 ∗ 𝜋 ∗ 𝐷22
𝑄𝑡𝑜𝑡𝑎𝑙 = 𝜋 ∗

𝑉𝑠𝑎𝑚𝑝𝑙𝑒 [(0.125𝐷22 )

𝑑22
+ ( )]
4

𝑅𝑎𝑡𝑒 𝑜𝑓 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑒𝑥𝑖𝑡 = 𝑸𝒔𝒂𝒎𝒑𝒍𝒆 ∗ 𝑪, 𝑤ℎ𝑒𝑟𝑒 𝐶 = 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
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Using these relations, we can determine what flow regime is needed to derive the values for
desired parameters.
As mentioned, the use of a tributary dispersed phase to induce hydrodynamic focusing is
effective but leads to the further dilution of the main sample stream within each droplet.
Serendipitously, we realized that we could achieve hydrodynamic focusing without the use of
tributary dispersed phases at a Qd/ Qc ≥ 100. This has not been reported anywhere to the best of
our knowledge.
While this is advantageous, it also presents challenges, in that the constriction of flow by the
continuous phase creates a vortex such that beads and even dissolved solids would have to reach
a critical mass before they can flow through. This concentrates the beads and could be
responsible for the encapsulation of multiple beads. A video showing the described phenomenon
is shown in the supplementary PowerPoint Slide as “the Dubem effect”.

Fig 5.5 Illustration of the “Dubem Effect”
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Working Theory for Single Bead Encapsulation Using Continuous Phase Induced
Hydrodynamic Focusing (Dubem Effect)
Having successfully generated droplets using our system, we can deduce the rate of droplet
formation per flow condition and consequently, the rate of query of the dispersed phase by the
continuous phase at the point of confluence. Hence, we theorize that by equating the rate of droplet
formation to the rate of bead introduction at the confluence point (Fig. 4.3 – Left), we can achieve
single bead encapsulation. This theory, however, assumes 100% mixing and agglomeration breakup efficiency of the in-syringe mixer and that the beads are introduced to the confluence as single
beads and not as agglomerates.
To test this, however, we needed to determine the rate of introduction of the beads to the
confluence point, P.
Number of droplets formed at point P per time

𝑑𝑟𝑜𝑝𝑙𝑒𝑡

µ𝑚3⁄
𝑚𝑖𝑛)
=
𝐷𝑟𝑜𝑝𝑙𝑒𝑡 𝑉𝑜𝑙𝑢𝑚𝑒 (µ𝑚3 )
𝑄(

𝑑𝑟𝑜𝑝𝑙𝑒𝑡 = 𝑏𝑒𝑎𝑑𝑠
Number of beads queried at point P, per time:
Q = volumetric flow rate, C = Bead Concentration



µ𝑚3⁄
𝑏𝑒𝑎𝑑𝑠⁄
𝑏𝑒𝑎𝑑𝑠=𝑄 (
)
𝑚𝑖𝑛)∗ 𝐶 (
µ𝑚3

Fig 5.6 Part 1 Illustration of the Working Theory for Single Bead Encapsulation
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Time it would take for QC beads to get to point P =
𝑸𝑪−𝟏 (𝑚𝑖𝑛𝑢𝑡𝑒⁄𝑏𝑒𝑎𝑑 )
Distance, x(µm) between two successive beads
µ𝒎
X = V * 𝑸𝑪−𝟏 , where V = velocity ( ⁄𝒎𝒊𝒏)
Volume of droplet required for each droplet to
encapsulate 1 bead each
= Surface area of shaded part (µ𝑚3 ) * X (µm)
= A * V* 𝑸𝑪−𝟏 , but A*V = Q
Droplet Volume = 𝑪−𝟏 (µ𝑚3 )
𝟑

𝟏

Diameter of Droplet = 2*(𝟒∗𝑪∗𝝅) 𝟑 (µm)

Fig 5.6 Part 2 Illustration of the Working Theory for Single Bead Encapsulation

Using this principle, settings and consumables described above we set up bead encapsulation
experiments such that  = 1.47E-01 beads/ drolet (250 µL of transparent 20 µm beads at 5% solid
in 1500 µL suspension). Using Poisson, we determined the predicted distribution of the beads.
From experimental data, a total of 34 micrographs (2.63E+04 droplets) were analyzed manually
to differentiate droplets with 0, 1, 2 and 3+ beads encapsulated. A comparison between the Poisson
prediction and the experimental data shows a better performance than predicted with respect to
single bead encapsulation. Although, more droplets than predicted had multiple beads in them, it
is not understood if this is due to bead agglomeration or the Dubem effect as visualization could
not be implemented with new set up. Figure 5.7 shows a comparison between our data and Poisson
prediction.
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Fig 5.7. Our method generates more single bead droplets and fewer empty droplets than
predicted by Poisson.

Following the results from our protocols, we believe that by improving the mixing regime to
prevent bead agglomeration and sedimentation, and optimizing the Dubem Effect, we may be
able to reduce the encapsulation of multiple beads.
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Thesis Conclusion
In this work, I set out to design platforms that would enable the application of LAMP in higherorder multiplexing; as well as, develope enabling unit processes. Embodied within this written
work are efforts geared at developing unit processes that would lead to the actualization of the
primer payload system/ platform.

By exploiting RNA chemistry, I designed a primer delivery system compatible with LAMP. In
fact, data from the RNA-dependent primer delivery shows that the developed assay/ reagents
improve LAMP speed compared to conventional LAMP systems. While this phenomenon, can be
argued to only have been demonstrated using E. coli gDNA, it shows promise that upon
optimization could be a unique improvement to LAMP chemistry.

Using simplistic tools, I designed protocols and methods for the fabrication of microfluidic
cartridges using 3D printing and soft lithography. I also developed

consumables, including

reagents which enabled the generation of monodisperse picoliter scale droplets. These were later
applied in droplet digital LAMP and dense bead encapsulation.

Dense bead manipulation is a very difficult principle in the field of bead-based research. In fact, a
lot of researchers prefer working with gel beads in order to improve yield (encapsulation
efficiency). This underscored the importance to generate a working theory and consumables which
would aid the encapsulation of single dense beads without the use of very expensive equipment.
In the course of developing this, I serendipitously observed two important phenomena which
affected working with the beads. These are the effect of curved flow focusing vertices which
enabled the characteristic conversion of flow focusing droplet generation regime into co-flow. It
led to a continuous phase-induced hydrodynamic focusing, thereby aiding laminar flow of the
beads.
A rather interesting but negative phenomenon emanating from this was the constriction of beads
at the encapsulation neck. This resulted to the beads waiting to reach a critical mass before they
are able to break through for encapsulation. Perhaps, this led to the encapsulation of more than one
bead in a few of the droplets. This constriction, however, is not restricted to beads, it is also
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effective against dissolved solids which keep circling till a critical mass is reached. Although I do
not yet know the cause of these serendipitous events, it is my hope that they can be exploited for
future use in various fields, for example for concentration dissolved solids or as a filtration system
or DNA concentration methods.

In effect, I was able to address the questions which made up the body of this work and were
highlighted in Chapter 1.
1. Can we successfully functionalize the bead surfaces with the primers?
Yes, I achieved this
2. What mechanism can we use to ensure the primers are available in solution when needed?
I developed a primer release system by exploiting RNA chemistry
3. Can the surface-bound primers successfully hybridize target DNA?
Yes, I demonstrated that bead-bound FIP could sequestrate DNA targets from solution
4. Can we successfully create a microfluidic chip for bead encapsulation and ddLAMP?
I designed and developed a microfluidic platform for this using 3D printing and soft
lithography. It was successfully applied in ddLAMP
5. How do we encapsulate only 1 bead per droplet without the use of very expensive tools?
For this, I developed a working theory and consumables which can be further optimized for
greater efficiency. At the moment, I recorded >200% more single bead encapsulation than
Poisson prediction and reduced the abundance of empty droplets by 25%.

Fig. 5.8 Variability in bead encapsulation between Poisson prediction and our process
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